Shanghai Int Medical Instruments invests in Broncus Holding through new share subscription
Shanghai Int Medical Instruments Co. Ltd. has announced a transaction involving the subscription of 91,093,613 new shares in Broncus Holding Corporation, formalized through a subscription agreement dated October 10, 2025. Broncus, listed on the Hong Kong Stock Exchange, specializes in interventional pulmonology devices. The completion of the transaction is subject to certain conditions outlined in the agreement.
Shanghai Int Medical Instruments Co. Ltd. has announced a discloseable transaction involving the subscription of 91,093,613 new shares in Broncus Holding Corporation. The investment was formalized through a subscription agreement dated 10 October 2025. Broncus, listed on the Hong Kong Stock Exchange, is a Cayman Islands-incorporated company specializing in interventional pulmonology devices for lung disease diagnosis and treatment. The completion of the transaction is subject to the satisfaction or waiver of conditions precedent outlined in the agreement. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shanghai Int Medical Instruments Co. Ltd. published the original content used to generate this news brief on October 10, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
